比较机器人辅助肾移植与开放肾移植能否减少手术并发症的开放标签随机临床试验(ORAKTx):随机临床试验研究方案
本研究为单中心、开放标签、优效性随机临床试验,计划纳入106例成人肾移植受者,按1:1随机分配至开放肾移植(OKT)或机器人辅助肾移植(RAKT),主要结局为术后30天血管及重大手术并发症,随访2年评估恢复、晚期并发症和移植肾功能。
要点
- 旨在比较RAKT与OKT术后30天血管及重大手术并发症。
- 计划纳入106例成人受者,1:1随机,随访2年。
- 采用意向性分析,优效性设计。
核心结论
- 研究将探索机器人辅助手术对比开放手术能否减少肾移植术后30天手术并发症。
研究设计与样本
- 单中心、开放标签、优效性随机临床试验,在丹麦哥本哈根大学医院-丹麦国家医院招募成人肾移植受者。
- 计划纳入106例参与者,按1:1随机分配至开放肾移植(OKT)组或机器人辅助肾移植(RAKT)组。
- 主要结局为术后30天血管及重大手术并发症,随访2年评估恢复、晚期并发症和移植肾功能,计划按意向性治疗原则分析。
局限性
- 据作者所知,尚无随机临床试验比较RAKT与OKT。
- 缺乏随机对照试验限制了将RAKT可减少若干手术并发症的研究结果外推,以支持用机器人辅助替代开放入路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kidney transplantation is the ultimate treatment for end-stage kidney disease. Function of the kidney graft is not only dependent on medical factors but also on a complication-free surgical procedure. In the event of major surgical complications, the kidney graft is potentially lost and the patient will return to the waiting list which may be long. To optimise peri-operative care and reduce complications, robot-assisted kidney transplantation (RAKT) has been introduced as an alternative to open kidney transplantation (OKT), but to our knowledge, no randomised clinical trials (RCT) have compared RAKT to OKT. In this study, we will explore whether robot-assisted surgery can reduce 30-day surgical complications compared to open surgery in kidney transplantation. METHODS: This is a single-site, open-label, randomised clinical trial comparing RAKT to OKT. Participants are adult recipients of kidney transplantation recruited from Copenhagen University Hospital - Rigshospitalet, Denmark. The study plans to include 106 participants who will be randomised in a 1:1 manner between OKT and RAKT. Primary outcomes are vascular- and major surgical complications at 30 days post-operatively. Participants will be followed for 2 years to evaluate secondary outcomes including recovery, late complications and kidney graft function. This is designed as a superiority trial and planned analyses will follow intention-to-treat principles. DISCUSSION: Studies indicate RAKT can reduce several surgical complications, but the lack of RCTs limits the extrapolation of these results to justify replacing an open approach with a robot-assisted one. Ultimately, the introduction of new surgical techniques should be as vigorously tested as any other new treatments. However, reducing surgical complications that compromise graft viability could lead to improved patient care and survival. TRIAL REGISTRATION: The trial was prospectively registered with ClinicalTrials.gov on February 15th, 2023, with the identifier NCT05730257.
引用
- Ortved M, Dagnæs-Hansen J, Stroomberg HV, et al. Open-label randomised clinical trial investigating whether robot-assisted kidney transplantation can reduce surgical complications compared to open kidney transplantation (ORAKTx): study protocol for a randomised clinical trial. Trials. 2025. PMID: 39762978. doi:10.1186/s13063-024-08706-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。